Mary Polan

Mary Lake Polan is currently a Non-Executive Director at Motif BioSciences, Inc. since 1993, a Director at Chembio Diagnostic Systems, Inc. since 2018, a Director at NovaTract Surgical, Inc., a Director at NX Prenatal, Inc., a Director at Or-Genix Therapeutics, Inc., an Independent Director at QuidelOrtho Corp.
since 1993, a Member of the National Academy of Medicine (United States), and a Professor at Yale School of Medicine since 2014.
Former positions include Director at Wyeth LLC from 1995 to 2009, Independent Director at Chembio Diagnostics, Inc. from 2018 to 2021, Independent Non-Executive Director at Motif Bio Plc from 2004 to 2019, Professor at Stanford University School of Medicine from 2005 to 2006, Independent Director at Quidel Corp., Director at Wyeth Pharmaceuticals LLC, Director at EpiEP, Inc., Director at MiraDx, Inc., Managing Director at Golden Seeds, Inc., and Clinical Professor at Columbia University Vagelos College of Physicians & Surgeons.
Education includes undergraduate studies at Connecticut College, graduate studies at the University of California, Berkeley, and a doctorate from Yale School of Medicine.